American Society of Hematology, Blood, 22(126), p. 2439-2440, 2015
DOI: 10.1182/blood-2015-10-671362
Full text: Download
In this issue of Blood, Copie-Bergman et al demonstrate that MYC rearrangements (MYC-Rs) with IG genes, but not with other partner genes, have a negative prognostic impact in patients with diffuse large B-cell lymphomas (DLBCLs) treated with immunochemotherapy.